LLY Eli Lilly and Company Common Stock
关于 Eli Lilly and Company Common Stock 公司概况(来自维基百科)
礼来公司 是美國的跨國製藥公司,总部位於印第安纳州首府印第安纳波利斯。禮來公司總計在全球55個國家進行大型臨床試驗,其產品銷往約120個國家。
阅读更多
礼来公司(英語:Eli Lilly and Company)是美國的跨國製藥公司,总部位於印第安纳州首府印第安纳波利斯。禮來公司總計在全球55個國家進行大型臨床試驗,其產品銷往約120個國家。
历史
1876年由药学家伊萊·利利创建,并最终以他的姓名命名。
2003年11月,禮來收購Applied Molecular Evolution (AME) 公司。
2008年向孟山都買下了保飼(POSILAC)產品,這是一種施打於乳牛的賀爾蒙人工激素(rBST),宣稱可以增加乳牛的乳汁產量,但卻會提高了乳牛罹患乳腺炎的機率。
2008年10月,禮來以每股70美元收購ImClone Systems公司,強化其在抗癌藥物上的研發能力。
2014年4月,武田藥品與禮來公司因惡意隱瞞糖尿病用藥吡格列酮(Acto)有可能導致癌症的風險,被美國路易斯安那州法院判決需支付60億美金的懲罰性賠償,而禮來公司作為經銷商則被罰以30億美元的巨額罰款。於2014年9月陪審團做出同法院判決的審議。
2014年4月22日,禮來製藥以54億美元現金收購諾華動物保健業務。
2018年5月12日,禮來製藥以每股50美元、斥資約16億美元收購Armo BioSciences公司(ARMO),以加強其抗癌藥物組合。
2018年9月20日,禮來製藥分拆旗下動物健康業務Elanco Animal Health Inc.(美股:ELAN)今日在紐約證券交易所上市,每股發行價24美元,發行6290萬股,集資15.096億美元。
2019年1月8日,禮來製藥以每股235美元現金,斥資80億美元收購癌症製藥公司Loxo Oncology。
2019年3月,原禮來旗下的禮來動保部門完成分拆工作,與禮來成為各自獨立的上市公司,禮來則專注於其在癌症、糖尿病、自體免疫疾病及疼痛等疾病領域的藥物研發工作。
2020年1月,禮來以每股18.75美金收購Dermira公司,以強化其在自體免疫疾病領域的研發實力。
2020年10月,禮來收購Disarm Therapeutics公司,加強其在周邊神經病變與其他神經性疾病的產品研發。
2022年10月,礼来研发的新一代治疗糖尿病和肥胖的替尔泊肽获得FDA快速通道资质。
产品
禮來產品橫跨思覺失調症、糖尿病、癌症治療,包括非小細胞肺癌、胃癌、大腸直腸癌、乳癌及肝癌等疾病領域,並在自體免疫疾病用藥,如乾癬、類風濕性關節炎、乾癬性關節炎、僵直性脊椎炎等領域有突破性的發展。
== 参考来源 ==
来源:维基百科, CC BY-SA 4.0 · 在维基百科上查看 ↗
LLY 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
LLY 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
10年表现 收入、净利润、利润率和每股收益趋势
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜?
盈利能力 毛利率、营业利润率和净利率;股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
财务健康 债务、流动性、偿付能力 — 资产负债表强度
成长 营收、每股收益 (EPS) 和净利润增长:同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
资本效率 资产周转率、库存周转率、应收账款周转率
股息 收益率、派息率、股息历史、5年CAGR
| 除息日 | 金额 |
|---|---|
| 2026年8月14日 | $1.7300 |
| 2026年5月15日 | $1.7300 |
| 2026年2月13日 | $1.7300 |
| 2025年11月14日 | $1.5000 |
| 2025年8月15日 | $1.5000 |
| 2025年5月16日 | $1.5000 |
| 2025年2月14日 | $1.5000 |
| 2024年11月15日 | $1.3000 |
| 2024年8月15日 | $1.3000 |
| 2024年5月15日 | $1.3000 |
| 2024年2月14日 | $1.3000 |
| 2023年11月14日 | $1.1300 |
| 2023年8月14日 | $1.1300 |
| 2023年5月12日 | $1.1300 |
| 2023年2月14日 | $1.1300 |
| 2022年11月14日 | $0.9800 |
| 2022年8月12日 | $0.9800 |
| 2022年5月13日 | $0.9800 |
| 2022年2月14日 | $0.9800 |
| 2021年11月12日 | $0.8500 |
LLY 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
- 强烈买入 11 28.9%
- 买入 19 50.0%
- 持有 7 18.4%
- 卖出 1 2.6%
- 强烈卖出 0 0.0%
12个月价格目标
27 位分析师 · 2026-08-15收益历史 每股收益实际值 vs 预估值,惊喜%,达标率,下次财报日期
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2026年6月30日 | $8.38 | $6.07 | 2.3% |
| 2026年3月31日 | $8.55 | $6.73 | 1.8% |
| 2025年12月31日 | $7.54 | $6.74 | 0.80% |
| 2025年9月30日 | $7.02 | $5.75 | 1.3% |
| 2025年6月30日 | $6.31 | $5.51 | 0.80% |
| 2025年3月31日 | $3.34 | $3.05 | 0.29% |
同行比较(GICS 子行业) 关键指标与行业同行对比
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| LLY | — | 46.8 | 44.7% | 31.7% | 101.2% | — |
| JNJ | — | 18.8 | 6.0% | 28.5% | 35.0% | 67.9% |
| MRK | — | 14.5 | 1.3% | 28.1% | 36.9% | — |
| PFE | — | 18.3 | -1.7% | 12.4% | 8.9% | — |
| BMY | — | 15.6 | -0.22% | 14.6% | 40.5% | — |
| RPRX | — | 21.7 | 5.1% | 32.4% | 8.0% | — |
| ZTS | $53.46B | 20.9 | 2.3% | 28.2% | 66.0% | — |
| VTRS | — | -4.2 | -3.0% | -24.6% | -23.2% | 35.1% |
| CORT | $3.69B | 42.4 | 12.8% | 13.1% | 15.5% | — |
| ELAN | $11.25B | -48.1 | 6.2% | -4.9% | -3.5% | 55.0% |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 15
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $65.18B | $45.04B | $34.12B | $28.54B | $28.32B | $24.54B | $22.32B | $21.49B | $19.97B | $21.22B | $19.96B | $19.62B | |
| Cost of Revenue | $11.05B | $8.42B | $7.08B | $6.63B | $7.31B | $5.48B | $4.72B | $4.68B | $4.45B | $5.71B | $5.04B | $4.93B | |
| R&D Expense | · | · | · | $7.19B | $6.93B | $5.98B | $5.59B | $5.05B | $5.10B | $5.31B | $4.80B | $4.73B | |
| SG&A Expense | $11.09B | $8.59B | $7.40B | $6.44B | $6.43B | $6.12B | $6.21B | $5.98B | $5.98B | $6.53B | $6.53B | $6.62B | |
| Interest Expense | · | · | $486M | $332M | $340M | $360M | $401M | $242M | $225M | $185M | $161M | $149M | |
| Interest Income | · | $175M | $174M | $63M | $25M | $33M | $80M | $159M | $166M | $109M | $87M | $121M | |
| Other Non-op | $-571M | $-219M | $97M | $-14M | $51M | $-196M | $-57M | $-12M | $111M | $196M | $342M | $368M | |
| Pretax Income | $25.73B | $12.68B | $6.55B | $6.81B | $6.16B | $7.23B | $5.27B | $3.68B | $2.30B | $3.37B | $2.79B | $3.00B | |
| Income Tax | $5.09B | $2.09B | $1.31B | $562M | $574M | $1.04B | $628M | $530M | $2.39B | $636M | $382M | $610M | |
| Net Income | $20.64B | $10.59B | $5.24B | $6.24B | $5.58B | $6.19B | $8.32B | $3.23B | $-204M | $2.74B | $2.41B | $2.39B | |
| EPS (Basic) | $23.00 | $11.76 | $5.82 | $6.93 | $6.15 | $6.82 | $8.93 | $3.14 | $-0.19 | $2.59 | $2.27 | $2.23 | |
| EPS (Diluted) | $22.95 | $11.71 | $5.80 | $6.90 | $6.12 | $6.79 | $8.89 | $3.13 | $-0.19 | $2.58 | $2.26 | $2.23 | |
| Shares (Basic) | 897,300,000 | 900,600,000 | 900,200,000 | 901,736,000 | 906,963,000 | 907,634,000 | 931,059,000 | 1,027,721,000 | 1,052,023,000 | 1,058,324,000 | 1,061,913,000 | 1,069,932,000 | |
| Shares (Diluted) | 899,300,000 | 904,100,000 | 903,300,000 | 904,619,000 | 911,681,000 | 912,505,000 | 935,684,000 | 1,033,667,000 | 1,052,023,000 | 1,061,825,000 | 1,065,720,000 | 1,074,286,000 | |
| EBITDA | $2.00B | $1.77B | $1.53B | $1.52B | $1.55B | $1.32B | $1.23B | $1.61B | $1.57B | $1.50B | $1.43B | $1.38B |
资产负债表 28
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $7.27B | $3.27B | $2.82B | $2.07B | $3.82B | $3.66B | $2.34B | $7.32B | $6.54B | $4.58B | $3.67B | $3.87B | |
| Short-term Investments | · | $155M | $109M | $145M | $90M | $24M | $101M | $88M | $1.50B | $1.46B | $785M | $955M | |
| Receivables | $17.76B | $11.01B | $9.09B | $6.90B | $6.67B | $5.88B | $4.55B | $4.59B | $4.55B | $4.03B | $3.51B | $3.23B | |
| Inventory | $13.74B | $7.59B | $5.77B | $4.31B | $3.89B | $3.98B | $3.19B | $3.10B | $4.46B | $3.56B | $3.45B | $2.74B | |
| Prepaid Expense | $14.31B | $8.34B | $5.54B | $2.95B | $2.53B | $2.87B | $2.54B | $2.04B | $1.45B | $735M | $604M | $560M | |
| Other Current Assets | $147M | $266M | $150M | $7M | · | · | · | · | · | · | · | · | |
| Current Assets | $55.63B | $32.74B | $25.73B | $18.03B | $18.45B | $17.46B | $13.71B | $20.55B | $19.20B | $15.10B | $12.57B | $11.93B | |
| PP&E (Net) | $24.68B | $17.10B | $12.91B | $10.14B | $8.99B | $8.68B | $7.87B | $8.00B | $8.83B | $8.25B | $8.05B | $7.96B | |
| PP&E (Gross) | · | $28.89B | $24.01B | $20.38B | $18.96B | $18.25B | $17.03B | $16.66B | $18.09B | $16.78B | $16.66B | $16.03B | |
| Accum. Depreciation | $12.56B | $11.79B | $11.10B | $10.23B | $9.98B | $9.57B | $9.16B | $8.67B | $9.26B | $8.53B | $8.61B | $8.07B | |
| Goodwill | $5.90B | $5.77B | $4.94B | $4.07B | $3.89B | $3.77B | $3.68B | $1.37B | $4.37B | $3.97B | $4.04B | $1.76B | |
| Intangibles | $6.52B | $6.17B | $6.91B | $7.21B | $7.69B | $7.45B | $6.62B | $1.07B | $4.03B | $4.36B | $5.03B | $2.88B | |
| Other Non-current Assets | $6.99B | $5.72B | $4.99B | $4.34B | $4.08B | $3.48B | $2.87B | $1.82B | $1.71B | $1.91B | $2.22B | $1.80B | |
| Total Assets | $112.48B | $78.72B | $64.01B | $49.49B | $48.81B | $46.63B | $39.29B | $43.91B | $44.98B | $38.81B | $35.57B | $36.31B | |
| Accounts Payable | $5.38B | $3.23B | $2.60B | $1.93B | $1.67B | $1.61B | $1.41B | $1.21B | $1.41B | $1.35B | $1.34B | $1.13B | |
| Short-term Debt | $0 | $4.34B | $6.19B | $1.50B | $0 | $0 | $1.49B | $499M | $2.70B | $1.30B | $0 | $2.68B | |
| Current Liabilities | $35.23B | $28.38B | $27.29B | $17.14B | $15.05B | $12.48B | $11.78B | $11.89B | $14.54B | $10.99B | $8.23B | $9.74B | |
| Capital Leases | $1.14B | $971M | $948M | · | · | · | $487M | $0 | · | · | · | · | |
| Deferred Tax | · | · | · | $87M | $1.73B | $2.10B | $2.19B | $1.31B | · | · | · | · | |
| Other Non-current Liabilities | $3.97B | $3.48B | $2.24B | $1.82B | $1.64B | $1.71B | $1.50B | $1.36B | $1.55B | $2.23B | $1.75B | $2.28B | |
| Long-term Debt | · | $29.47B | $19.10B | $14.82B | $16.74B | $16.35B | $13.64B | · | · | $9.01B | $7.98B | · | |
| Total Debt | $40.87B | $32.86B | $24.51B | $16.24B | $15.35B | $16.59B | $15.31B | $12.14B | $12.64B | $9.67B | $7.97B | $8.05B | |
| Common Stock | $590M | $592M | $594M | $594M | $596M | $598M | $599M | $661M | $688M | $688M | $691M | $695M | |
| Retained Earnings | $24.47B | $13.54B | $10.31B | $10.04B | $8.96B | $7.83B | $4.92B | $11.40B | $13.89B | $16.05B | $16.01B | $16.48B | |
| Treasury Stock | · | $50M | $44M | $50M | $53M | $56M | $61M | $69M | $76M | $80M | $90M | $91M | |
| AOCI | $-2.88B | $-4.32B | $-4.33B | $-3.84B | $-4.34B | $-6.50B | $-6.52B | $-5.73B | $-5.72B | $-5.27B | $-4.58B | $-3.99B | |
| Stockholders' Equity | $26.54B | $14.27B | $10.77B | $10.65B | $8.98B | $5.64B | $2.61B | $9.83B | $11.59B | $14.01B | $14.57B | $15.37B | |
| Liabilities + Equity | $112.48B | $78.72B | $64.01B | $49.49B | $48.81B | $46.63B | $39.29B | $43.91B | $44.98B | $38.81B | $35.57B | $36.31B |
现金流 15
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2.00B | $1.77B | $1.53B | $1.52B | $1.55B | $1.32B | $1.23B | $1.61B | $1.57B | $1.50B | $1.43B | $1.38B | |
| Stock-based Comp | $626M | $646M | $629M | $371M | $343M | $308M | $312M | $280M | $281M | $255M | $218M | $156M | |
| Deferred Tax | $-1.71B | $-2.68B | $-2.34B | $-2.19B | $-802M | $-134M | $62M | $248M | $-832M | $440M | $-748M | $37M | |
| Amort. of Intangibles | $488M | $553M | $506M | $580M | $629M | $428M | $226M | $361M | $462M | $688M | $632M | $536M | |
| Other Non-cash | $-4.74B | $-1.50B | $-815M | $1.13B | $591M | $-1.19B | $-5.09B | $77M | $4.76B | $-78M | $-533M | $405M | |
| Operating Cash Flow | $16.81B | $8.82B | $4.24B | $7.59B | $7.37B | $6.50B | $4.84B | $5.52B | $5.62B | $4.85B | $2.96B | $4.46B | |
| Investing Cash Flow | $-10.97B | $-9.30B | $-7.15B | $-3.76B | $-2.87B | $-2.26B | $-8.08B | $1.91B | $-3.78B | $-3.14B | $27M | $-3.91B | |
| Debt Issued | $13.17B | $11.42B | $3.96B | $0 | $2.41B | $2.06B | $6.56B | $2.48B | $2.23B | $1.21B | $4.45B | $993M | |
| Net Debt Issued | $12.39B | $10.75B | $3.96B | $-1.56B | $505M | $1.79B | $3.69B | $1.47B | $1.60B | $1.21B | $2.50B | $-42M | |
| Stock Repurchased | $4.11B | $2.50B | $750M | $1.50B | $1.25B | $500M | $4.40B | $4.15B | $300M | $600M | $750M | $800M | |
| Net Stock Activity | $-4.11B | $-2.50B | $-750M | $-1.50B | $-1.25B | $-500M | $-4.40B | $-4.15B | $-300M | $-600M | $-750M | $-800M | |
| Dividends Paid | $5.38B | $4.68B | $4.07B | $3.54B | $3.09B | $2.69B | $2.41B | $2.31B | $2.19B | $2.16B | $2.13B | $2.10B | |
| Financing Cash Flow | $-2.21B | $1.23B | $3.50B | $-5.41B | $-4.13B | $-3.14B | $-2.32B | $-5.90B | $143M | $-560M | $-3.11B | $-166M | |
| Net Change in Cash | $4.00B | $449M | $752M | $-1.75B | $161M | $1.32B | $-5.66B | $1.46B | $1.95B | $916M | $-205M | $41M | |
| Taxes Paid | $10.81B | $6.56B | $5.56B | · | · | · | · | · | · | · | · | · |
盈利能力 5
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Margin | 31.7% | 23.5% | 15.4% | 21.9% | 19.7% | 25.2% | 37.3% | 13.2% | -0.89% | 12.9% | 12.1% | 12.2% | |
| Pretax Margin | 39.5% | 28.1% | 19.2% | 23.8% | 21.7% | 29.5% | 23.6% | 15.5% | 9.6% | 15.9% | 14.0% | 15.3% | |
| EBITDA Margin | 3.1% | 3.9% | 4.5% | 5.3% | 5.5% | 5.4% | 5.5% | 6.6% | 6.9% | 7.0% | 7.1% | 7.0% | |
| ROA | 21.6% | 14.8% | 9.2% | 12.7% | 11.7% | 14.4% | 20.0% | 7.3% | -0.49% | 7.4% | 6.7% | 6.6% | |
| ROE | 101.2% | 84.8% | 48.9% | 63.6% | 76.3% | 150.2% | 133.8% | 30.2% | -1.6% | 19.2% | 16.1% | 14.5% |
流动性与偿付能力 4
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.6 | 1.2 | 0.9 | 1.1 | 1.2 | 1.4 | 1.2 | 1.7 | 1.3 | 1.4 | 1.5 | 1.1 | |
| Quick Ratio | 0.7 | 0.5 | 0.4 | 0.5 | 0.7 | 0.8 | 0.6 | 1.1 | 0.9 | 0.9 | 1.0 | 0.7 | |
| Debt / Equity | 1.5 | 2.3 | 2.3 | 1.5 | 1.7 | 2.9 | 5.9 | 1.2 | 1.1 | 0.7 | 0.5 | 0.5 | |
| LT Debt / Equity | 1.5 | 2.0 | 1.7 | 1.4 | 1.7 | 2.9 | 5.3 | 1.2 | 0.9 | 0.6 | 0.5 | 0.3 |
效率 3
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.7 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.5 | 0.6 | 0.5 | 0.6 | 0.6 | 0.5 | |
| Inventory Turnover | 1.0 | 1.3 | 1.4 | 1.6 | 1.9 | 1.5 | 1.5 | 1.5 | 1.5 | 1.6 | 1.6 | 1.7 | |
| Receivables Turnover | 4.5 | 4.5 | 4.3 | 4.2 | 4.5 | 4.7 | 4.9 | 5.0 | 5.3 | 5.6 | 5.9 | 5.9 |
增长率 10
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 44.7% | 32.0% | 19.6% | 0.79% | 15.4% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 31.7% | 16.7% | 11.6% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 21.6% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 96.0% | 101.9% | -15.9% | 12.8% | -9.9% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 49.3% | 24.1% | -5.1% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 27.6% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 94.9% | 102.1% | -16.1% | 11.9% | -9.9% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 49.0% | 23.8% | -5.4% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 27.2% | · | · | · | · | · | · | · | · | · | · | · | |
| Dividend CAGR 5Y | 14.9% | · | · | · | · | · | · | · | · | · | · | · |
估值 (TTM) 6
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $65.18B | $45.04B | $34.12B | $28.54B | $28.32B | $24.54B | $22.32B | $21.49B | $19.97B | $21.22B | $19.96B | $19.62B | |
| Net Income TTM | $20.64B | $10.59B | $5.24B | $6.24B | $5.58B | $6.19B | $8.32B | $3.23B | $-204M | $2.74B | $2.41B | $2.39B | |
| P/E | 46.8 | 65.9 | 100.5 | 53.0 | 45.1 | 24.9 | 14.8 | 37.0 | -444.5 | 28.5 | 37.3 | 30.9 | |
| Earnings Yield | 2.1% | 1.5% | 0.99% | 1.9% | 2.2% | 4.0% | 6.8% | 2.7% | -0.22% | 3.5% | 2.7% | 3.2% | |
| Payout Ratio | 26.1% | 44.2% | 77.6% | 56.6% | 55.3% | 43.4% | 29.0% | 71.5% | -1074.0% | 78.8% | 88.3% | 87.9% | |
| Annual Payout | $5.38B | $4.68B | $4.07B | $3.54B | $3.09B | $2.69B | $2.41B | $2.31B | $2.19B | $2.16B | $2.13B | $2.10B |
损益表 15
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $22.97B | $19.80B | $19.29B | $17.60B | $15.56B | $12.73B | $13.53B | $11.44B | $11.30B | $8.77B | $9.35B | $9.50B | $8.31B | $6.96B | $7.30B | $6.94B | |
| Cost of Revenue | $3.27B | $3.58B | $3.37B | $3.01B | $2.45B | $2.23B | $2.40B | $2.17B | $2.17B | $1.67B | $1.79B | $1.86B | $1.81B | $1.63B | $1.55B | $1.58B | |
| R&D Expense | · | · | · | · | · | · | · | · | · | · | · | · | $2.36B | $1.99B | · | $1.80B | |
| SG&A Expense | $3.43B | $2.93B | $3.13B | $2.74B | $2.75B | $2.47B | $2.42B | $2.10B | $2.12B | $1.95B | $1.93B | $1.80B | $1.93B | $1.75B | $1.64B | $1.61B | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $180M | · | $125M | $120M | $103M | · | $82M | |
| Interest Income | · | · | · | $65M | $40M | $48M | · | $48M | $37M | $46M | · | $49M | $46M | $34M | $26M | $20M | |
| Other Non-op | $269M | $-65M | $-287M | $-179M | $-90M | $-239M | $-219M | $-21M | $-8M | $29M | $108M | $-100.0K | $-13M | $2M | $-31M | $-19M | |
| Pretax Income | $9.25B | $8.85B | $8.27B | $7.23B | $6.78B | $3.46B | $5.04B | $1.59B | $3.52B | $2.54B | $2.51B | $427M | $2.09B | $1.53B | $2.10B | $1.57B | |
| Income Tax | $2.15B | $1.45B | $1.63B | $1.65B | $1.12B | $697M | $628M | $618M | $550M | $293M | $319M | $485M | $326M | $185M | $159M | $114M | |
| Net Income | $7.09B | $7.40B | $6.64B | $5.58B | $5.66B | $2.76B | $4.41B | $970M | $2.97B | $2.24B | $2.19B | $-57M | $1.76B | $1.34B | $1.94B | $1.45B | |
| EPS (Basic) | $7.95 | $8.27 | $7.41 | $6.22 | $6.30 | $3.07 | $4.90 | $1.08 | $3.29 | $2.49 | $2.43 | $-0.06 | $1.96 | $1.49 | $2.15 | $1.61 | |
| EPS (Diluted) | $7.94 | $8.26 | $7.39 | $6.21 | $6.29 | $3.06 | $4.88 | $1.07 | $3.28 | $2.48 | $2.42 | $-0.06 | $1.95 | $1.49 | $2.14 | $1.61 | |
| Shares (Basic) | 892,400,000 | 894,500,000 | -1,796,200,000 | 896,900,000 | 897,900,000 | 898,700,000 | -1,802,100,000 | 901,000,000 | 900,900,000 | 900,800,000 | -1,800,300,000 | 899,800,000 | 899,700,000 | 901,000,000 | -1,802,964,000 | 900,700,000 | |
| Shares (Diluted) | 893,700,000 | 895,900,000 | -1,799,900,000 | 898,800,000 | 899,800,000 | 900,600,000 | -1,808,900,000 | 905,000,000 | 904,200,000 | 903,800,000 | -1,802,500,000 | 899,800,000 | 902,700,000 | 903,300,000 | -1,808,481,000 | 903,800,000 | |
| EBITDA | · | $509M | · | · | · | $463M | · | · | · | $401M | · | · | · | $362M | · | · |
资产负债表 26
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $8.95B | $5.28B | $7.27B | $9.79B | $3.38B | $3.09B | $3.27B | $3.37B | $3.22B | $2.46B | · | $2.38B | $2.69B | $3.55B | · | $2.62B | |
| Short-term Investments | · | · | · | $122M | $170M | $127M | · | $149M | $140M | $126M | · | $113M | $135M | $123M | · | $125M | |
| Receivables | $20.08B | $18.43B | $17.76B | $16.11B | $14.17B | $12.04B | $11.01B | $10.29B | $11.03B | $7.89B | · | $8.17B | $7.52B | $7.53B | · | $6.72B | |
| Inventory | $16.79B | $14.53B | $13.74B | $12.18B | $11.01B | $9.31B | $7.59B | $7.46B | $6.48B | $6.10B | · | $4.90B | $4.80B | $4.54B | · | $3.83B | |
| Prepaid Expense | $15.37B | $13.63B | $14.31B | $20.25B | $18.02B | $14.65B | $8.34B | $8.25B | $7.14B | $6.35B | · | $5.25B | $4.53B | $3.58B | · | $2.74B | |
| Other Current Assets | $86M | $214M | $147M | $272M | $69M | $72M | $266M | $135M | $142M | $139M | · | · | · | · | · | · | |
| Current Assets | $64.67B | $54.84B | $55.63B | $62.07B | $49.85B | $41.26B | $32.74B | $31.42B | $30.20B | $25.19B | · | $23.01B | $21.33B | $20.81B | · | $17.64B | |
| PP&E (Net) | $29.29B | $26.54B | $24.68B | $22.32B | $20.53B | $18.47B | $17.10B | $16.17B | $14.83B | $13.62B | · | $11.86B | $11.28B | $10.55B | · | $9.31B | |
| Accum. Depreciation | $13.10B | · | $12.56B | $12.41B | $12.55B | $12.15B | $11.79B | $11.82B | $11.43B | $11.23B | · | $10.77B | $10.63B | $10.49B | · | $10.07B | |
| Goodwill | $8.85B | $6.13B | $5.90B | $5.90B | $5.77B | $5.77B | $5.77B | $5.77B | $5.77B | $4.94B | · | $4.09B | $4.08B | $4.07B | · | $3.89B | |
| Intangibles | $18.11B | $7.37B | $6.52B | $6.45B | $5.91B | $6.01B | $6.17B | $6.54B | $6.64B | $6.76B | · | $6.78B | $6.90B | $7.09B | · | $7.12B | |
| Other Non-current Assets | $7.48B | $7.23B | $6.99B | $6.43B | $6.23B | $6.07B | $5.72B | $5.12B | $4.90B | $4.71B | · | $4.91B | $4.67B | $4.49B | · | $4.54B | |
| Total Assets | $142.28B | $116.58B | $112.48B | $114.94B | $100.92B | $89.39B | $78.72B | $75.61B | $71.87B | $63.94B | · | $57.92B | $54.81B | $53.16B | · | $47.46B | |
| Accounts Payable | $6.11B | $5.03B | $5.38B | $4.26B | $4.08B | $3.44B | $3.23B | $2.89B | $2.92B | $2.47B | · | $2.44B | $2.47B | $2.02B | · | $1.68B | |
| Short-term Debt | · | · | $0 | · | · | · | $4.34B | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $47.74B | $36.63B | $35.23B | $40.14B | $39.02B | $30.07B | $28.38B | $24.67B | $27.12B | $18.60B | · | $22.00B | $18.91B | $16.01B | · | $15.65B | |
| Capital Leases | · | · | $1.14B | · | · | · | $971M | · | · | · | · | · | · | · | · | · | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $172M | |
| Other Non-current Liabilities | $7.34B | $4.08B | $3.97B | $3.78B | $2.34B | $2.29B | $3.48B | $2.24B | $2.47B | $2.27B | · | $1.91B | $1.95B | $1.82B | · | $1.85B | |
| Total Debt | $47.86B | $39.37B | · | $40.87B | $34.18B | $34.50B | · | $29.05B | $23.73B | $24.56B | · | $17.92B | $18.16B | $18.88B | · | $14.14B | |
| Common Stock | $588M | $590M | $590M | $591M | $592M | $593M | $592M | $594M | $594M | $594M | · | $594M | $594M | $594M | · | $594M | |
| Retained Earnings | $31.89B | $29.51B | $24.47B | $22.25B | $17.38B | $15.10B | $13.54B | $13.63B | $13.18B | $12.55B | · | $10.31B | $10.37B | $10.64B | · | $10.01B | |
| Treasury Stock | · | · | · | $62M | $55M | $50M | · | $33M | $33M | $33M | · | $45M | $45M | $45M | · | $50M | |
| AOCI | $-2.76B | $-2.83B | $-2.88B | $-3.21B | $-3.72B | $-3.77B | $-4.32B | $-4.27B | $-4.38B | $-4.30B | · | $-3.78B | $-3.79B | $-3.78B | · | $-4.30B | |
| Stockholders' Equity | $33.88B | $31.20B | $26.54B | $23.79B | $18.27B | $15.76B | $14.27B | $14.24B | $13.56B | $12.81B | · | $11.22B | $11.06B | $11.19B | · | $10.07B | |
| Liabilities + Equity | $142.28B | $116.58B | $112.48B | $114.94B | $100.92B | $89.39B | $78.72B | $75.61B | $71.87B | $63.94B | · | $57.92B | $54.81B | $53.16B | · | $47.46B |
现金流 13
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $534M | $509M | $586M | $470M | $478M | $463M | $485M | $467M | $414M | $401M | $387M | $411M | $366M | $362M | $375M | $363M | |
| Stock-based Comp | $201M | $161M | $136M | $151M | $185M | $154M | $142M | $133M | $211M | $159M | $121M | $216M | $162M | $131M | $93M | $85M | |
| Other Non-cash | · | $-2.73B | · | · | · | $-1.71B | · | · | · | $-1.64B | · | · | · | $-108M | · | · | |
| Operating Cash Flow | $10.69B | $5.33B | $3.22B | $8.84B | $3.09B | $1.67B | $2.47B | $3.71B | $1.47B | $1.17B | $-312M | $2.19B | $632M | $1.73B | $1.66B | $2.60B | |
| CapEx | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $617M | |
| Investing Cash Flow | $-15.40B | $-3.92B | $-2.80B | $-2.98B | $-1.83B | $-3.35B | $-1.92B | $-4.00B | $-2.20B | $-1.18B | $-2.92B | $-3.08B | $-459M | $-689M | $-944M | $-1.34B | |
| Debt Issued | $8.94B | $0 | $-200.0K | $6.71B | $0 | $6.46B | $-100.0K | $4.96B | $0 | $6.45B | $500.0K | $0 | $0 | $3.96B | $0 | $0 | |
| Net Debt Issued | · | $-750M | · | · | · | $6.46B | · | · | · | $6.45B | · | · | · | $3.96B | · | · | |
| Stock Repurchased | $1.60B | $2.36B | $1.51B | $708M | $692M | $1.20B | $2.05B | $446M | $0 | $0 | $0 | $0 | $0 | $750M | $0 | $0 | |
| Net Stock Activity | · | $-2.36B | · | · | · | $-1.20B | · | · | · | $0 | · | · | · | $-750M | · | · | |
| Dividends Paid | $1.55B | $1.55B | $1.35B | $1.35B | $1.35B | $1.35B | $1.17B | $1.17B | $1.17B | $1.17B | $1.02B | $1.02B | $1.02B | $1.02B | $884M | $882M | |
| Financing Cash Flow | $8.43B | $-3.47B | $-2.88B | $531M | $-1.24B | $1.38B | $-226M | $211M | $1.56B | $-311M | $3.55B | $572M | $-1.03B | $412M | $-1.14B | $-1.26B | |
| Net Change in Cash | $3.67B | $-1.99B | $-2.52B | $6.42B | $283M | $-175M | $-101M | $145M | $763M | $-358M | $438M | $-314M | $-851M | $1.48B | $-550M | $-6M |
盈利能力 5
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Margin | 30.9% | 37.4% | · | 31.7% | 36.4% | 21.7% | · | 8.5% | 26.2% | 25.6% | · | -0.60% | 21.2% | 19.3% | · | 20.9% | |
| Pretax Margin | 40.2% | 44.7% | · | 41.1% | 43.6% | 27.2% | · | 13.9% | 31.1% | 28.9% | · | 4.5% | 25.1% | 22.0% | · | 22.6% | |
| EBITDA Margin | · | 2.6% | · | · | · | 3.6% | · | · | · | 4.6% | · | · | · | 5.2% | · | · | |
| ROA | 5.8% | 7.2% | · | 5.9% | 6.6% | 3.6% | · | 1.5% | 4.7% | 3.8% | · | -0.11% | 3.5% | 2.7% | · | 3.0% | |
| ROE | 27.2% | 31.5% | · | 29.4% | 35.6% | 19.3% | · | 7.6% | 24.1% | 18.7% | · | -0.54% | 18.0% | 13.1% | · | 16.3% |
流动性与偿付能力 4
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.4 | 1.5 | · | 1.5 | 1.3 | 1.4 | · | 1.3 | 1.1 | 1.4 | · | 1.0 | 1.1 | 1.3 | · | 1.1 | |
| Quick Ratio | 0.6 | 0.6 | · | 0.6 | 0.5 | 0.5 | · | 0.6 | 0.5 | 0.6 | · | 0.5 | 0.5 | 0.7 | · | 0.6 | |
| Debt / Equity | 1.4 | 1.3 | · | 1.7 | 1.9 | 2.2 | · | 2.0 | 1.7 | 1.9 | · | 1.6 | 1.6 | 1.7 | · | 1.4 | |
| LT Debt / Equity | 1.4 | 1.3 | · | 1.7 | 1.9 | 2.2 | · | 2.0 | 1.7 | 1.9 | · | 1.6 | 1.6 | 1.7 | · | 1.4 |
效率 3
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.2 | 0.2 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.2 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.4 | 0.4 | 0.3 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | |
| Receivables Turnover | 1.3 | 1.3 | · | 1.3 | 1.2 | 1.3 | · | 1.2 | 1.2 | 1.1 | · | 1.3 | 1.2 | 1.0 | · | 1.1 |
估值 (TTM) 5
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $75.93B | $65.69B | · | $57.33B | $51.03B | $44.24B | · | $41.01B | $37.88B | $33.54B | · | $31.71B | $28.70B | $28.20B | · | $28.01B | |
| Net Income TTM | $25.73B | $21.40B | · | $14.97B | $12.36B | $8.94B | · | $6.12B | $6.92B | $5.29B | · | $4.50B | $5.51B | $5.65B | · | $5.42B | |
| P/E | 41.8 | 38.6 | · | 45.9 | 56.9 | 83.5 | · | 130.9 | 118.4 | 132.8 | · | 107.6 | 76.9 | 54.9 | · | 54.1 | |
| Earnings Yield | 2.4% | 2.6% | · | 2.2% | 1.8% | 1.2% | · | 0.76% | 0.84% | 0.75% | · | 0.93% | 1.3% | 1.8% | · | 1.8% | |
| Payout Ratio | · | 20.9% | · | · | · | 48.8% | · | · | · | 52.1% | · | · | · | 75.6% | · | · |
财务报表 损益表、资产负债表、现金流量表 — 年度,近5年
损益表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 收入 | $65.18B | $45.04B | $34.12B | $28.54B | $28.32B |
| 净收入 | $20.64B | $10.59B | $5.24B | $6.24B | $5.58B |
| 稀释后每股收益 (EPS) | $22.95 | $11.71 | $5.80 | $6.90 | $6.12 |
资产负债表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 负债/股东权益比率 | 1.5 | 2.3 | 2.3 | 1.5 | 1.7 |
| 流动比率 | 1.6 | 1.2 | 0.9 | 1.1 | 1.2 |
| 速动比率 | 0.7 | 0.5 | 0.4 | 0.5 | 0.7 |
最新新闻 提及该公司的近期头条新闻
- Three Center-Stage AI Players Join Eli Lilly On Elite Screen
- Eli Lilly vs. Novo Nordisk: Which Company Is Better Positioned for America’s New Drug Manufacturing Policies?
- Eli Lilly and Company (LLY) vs. Novo Nordisk A/S (NVO): Is Lilly Pulling Ahead in the $100 Billion Obesity Market?
- SPYM, GOOGL, LLY, BRK.B: Large Inflows Detected at ETF
- Lilly's Mounjaro, Zepbound sales surge, widening lead over Novo Nordisk
- "Deceptive Advertising!" Claims Novo Nordisk in Explosive New GLP-1 Lawsuit Against Eli Lilly. Here's What That Means for Both Stocks.
- Ozempic-maker sues rival, accusing it of false advertising
- The market for psychedelic drugs to treat mental health conditions gets a big buy signal
- Eli Lilly to Pay up to $3.8B for AtaiBeckley in Big Pharma’s Latest Psychedelic Foray
- AtaiBeckley (ATAI) Soars to 4-Year High on $3.8B Merger with Eli Lilly
我的指标 您的个人关注列表 — 来自完整基本面的选定行
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存,并会跟随您浏览所有股票。
机构持有人 (13F) 5056 家申报者 · $618.6B 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸;单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存,而非方向性判断。
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 387 (+101 与上一季度对比) | 87 (-138 与上一季度对比) | 2166 (+236 与上一季度对比) | 1485 (-237 与上一季度对比) | +25.6M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天,外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过,优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| LILLY ENDOWMENT INC | $108400858723 | 90376978 | 17.52% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $64204130146 | 53528868 | 10.38% | 股份 |
| STATE STREET CORP | $43438261820 | 36215754 | 7.02% | 股份 |
| Capital Research Global Investors | $25037481632 | 20873140 | 4.05% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $25019170646 | 20859217 | 4.04% | 股份 |
| FMR LLC | $23272664162 | 19403104 | 3.76% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $21252395665 | 17790304 | 3.44% | 股份 |
| Capital World Investors | $19076022904 | 15902642 | 3.08% | 股份 |
| NORGES BANK | $13759156895 | 11471413 | 2.22% | 股份 |
| WELLINGTON MANAGEMENT GROUP LLP | $12172183865 | 10148307 | 1.97% | 股份 |
| PRIMECAP MANAGEMENT CO/CA/ | $11002256246 | 9172904 | 1.78% | 股份 |
| STATE FARM MUTUAL AUTOMOBILE INSURANCE CO | $8853660913 | 7381557 | 1.43% | 股份 |
| UBS Group AG | $8756297182 | 7300382 | 1.42% | 买入期权 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $7198575852 | 6001664 | 1.16% | 股份 |
| Capital International Investors | $6879841625 | 5734768 | 1.11% | 股份 |
| JENNISON ASSOCIATES LLC | $6415075179 | 5348436 | 1.04% | 股份 |
| Fisher Asset Management, LLC | $6073333633 | 5063516 | 0.98% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $5508155583 | 4592311 | 0.89% | 股份 |
| DIMENSIONAL FUND ADVISORS LP | $4288683267 | 3575603 | 0.69% | 股份 |
| ALLIANCEBERNSTEIN L.P. | $3916450563 | 4258076 | 0.63% | 股份 |
| JANE STREET GROUP, LLC | $3018245652 | 2516400 | 0.49% | 卖出期权 |
| AMERICAN CENTURY COMPANIES INC | $2824462145 | 2354837 | 0.46% | 股份 |
| CITADEL ADVISORS LLC | $2817700956 | 2349200 | 0.46% | 卖出期权 |
| Swiss National Bank | $2716888865 | 2265150 | 0.44% | 股份 |
| UBS Group AG | $2674269518 | 2229617 | 0.43% | 股份 |
| BlackRock, Inc. | $2610637358 | 2176565 | 0.42% | 股份 |
| VICTORY CAPITAL MANAGEMENT INC | $2568591611 | 2141447 | 0.42% | 股份 |
| JANE STREET GROUP, LLC | $2536674507 | 2114900 | 0.41% | 买入期权 |
| Mitsubishi UFJ Asset Management Co., Ltd. | $2415287393 | 2013696 | 0.39% | 股份 |
| GOLDMAN SACHS GROUP INC | $2358324528 | 1966204 | 0.38% | 股份 |
| Sumitomo Mitsui Trust Group, Inc. | $2273837414 | 1895765 | 0.37% | 股份 |
| CITADEL ADVISORS LLC | $2256727545 | 1881500 | 0.36% | 买入期权 |
| Legal & General Group Plc | $2202867142 | 1836595 | 0.36% | 股份 |
| FIFTH THIRD BANCORP | $2099946659 | 1750788 | 0.34% | 股份 |
| BANK OF AMERICA CORP /DE/ | $2060238592 | 1717681 | 0.33% | 股份 |
| CANADA PENSION PLAN INVESTMENT BOARD | $2057106410 | 1715070 | 0.33% | 股份 |
| Vanguard Global Advisers, LLC | $2048187448 | 1707634 | 0.33% | 股份 |
| National Pension Service | $2018379214 | 1682782 | 0.33% | 股份 |
| NEUBERGER BERMAN GROUP LLC | $1973413342 | 1645037 | 0.32% | 股份 |
| AMERIPRISE FINANCIAL INC | $1955279981 | 1630180 | 0.32% | 股份 |
| VANGUARD ASSET MANAGEMENT, Ltd | $1867073519 | 1556634 | 0.30% | 股份 |
| VANGUARD GROUP INC | $1858925581 | 1729748 | 0.30% | 股份 |
| SAPIENT CAPITAL LLC | $1736223301 | 1447540 | 0.28% | 股份 |
| California Public Employees Retirement System | $1727998411 | 1440683 | 0.28% | 股份 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $1604453190 | 1337665 | 0.26% | 股份 |
| RHUMBLINE ADVISERS | $1599208304 | 1333307 | 0.26% | 股份 |
| LPL Financial LLC | $1529042537 | 1274807 | 0.25% | 股份 |
| US BANCORP \DE\ | $1525382299 | 1271756 | 0.25% | 股份 |
| PeakShares LLC | $1459706000 | 1217 | 0.24% | 股份 |
| ENVESTNET ASSET MANAGEMENT INC | $1410361452 | 1175866 | 0.23% | 股份 |
| RAYMOND JAMES FINANCIAL INC | $1378916702 | 1149643 | 0.22% | 股份 |
| APG Asset Management N.V. | $1269741378 | 1210321 | 0.21% | 股份 |
| TD Asset Management Inc | $1203590823 | 1003469 | 0.19% | 股份 |
| COMERICA BANK | $1187462066 | 1104945 | 0.19% | 股份 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $1182373533 | 1285510 | 0.19% | 股份 |
| BNP PARIBAS FINANCIAL MARKETS | $1153247147 | 961496 | 0.19% | 股份 |
| NORDEA INVESTMENT MANAGEMENT AB | $1140281246 | 946590 | 0.18% | 股份 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $1117172877 | 1214622 | 0.18% | 股份 |
| Bank Julius Baer & Co. Ltd, Zurich | $1100986977 | 913248 | 0.18% | 股份 |
| Ensign Peak Advisors, Inc | $1073804101 | 895262 | 0.17% | 股份 |
| PNC Financial Services Group, Inc. | $1055920599 | 880352 | 0.17% | 股份 |
| NEW YORK STATE COMMON RETIREMENT FUND | $1038211015 | 865587 | 0.17% | 股份 |
| Caisse de depot et placement du Quebec | $966511489 | 805809 | 0.16% | 股份 |
| Robeco Institutional Asset Management B.V. | $910055515 | 758740 | 0.15% | 股份 |
| Pictet Asset Management Holding SA | $905835797 | 754985 | 0.15% | 股份 |
| BARCLAYS PLC | $904852390 | 754402 | 0.15% | 股份 |
| Grantham, Mayo, Van Otterloo & Co. LLC | $892337542 | 743966 | 0.14% | 股份 |
| PRUDENTIAL FINANCIAL INC | $879194184 | 733010 | 0.14% | 股份 |
| CITADEL ADVISORS LLC | $874462433 | 729065 | 0.14% | 股份 |
| JONES FINANCIAL COMPANIES LLLP | $874355284 | 723732 | 0.14% | 股份 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $871024867 | 726199 | 0.14% | 股份 |
| AVIVA PLC | $861503791 | 718261 | 0.14% | 股份 |
| LAZARD ASSET MANAGEMENT LLC | $828834772 | 691024 | 0.13% | 股份 |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $819673670 | 683386 | 0.13% | 股份 |
| CIBC Bancorp USA Inc. | $819454832 | 683299 | 0.13% | 股份 |
| POLEN CAPITAL MANAGEMENT LLC | $799914391 | 666912 | 0.13% | 股份 |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $792908390 | 661071 | 0.13% | 股份 |
| Korea Investment CORP | $790364399 | 658950 | 0.13% | 股份 |
| Bahl & Gaynor LLC | $786973674 | 656123 | 0.13% | 股份 |
| ROYAL LONDON ASSET MANAGEMENT LTD | $774668656 | 645864 | 0.13% | 股份 |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $729268278 | 610128 | 0.12% | 股份 |
| GOLDMAN SACHS GROUP INC | $697588488 | 581600 | 0.11% | 卖出期权 |
| MACKENZIE FINANCIAL CORP | $696221138 | 580460 | 0.11% | 股份 |
| Ninety One UK Ltd | $684160837 | 570405 | 0.11% | 股份 |
| WOLVERINE TRADING, LLC | $675581649 | 929900 | 0.11% | 卖出期权 |
| WOLVERINE TRADING, LLC | $665773764 | 916400 | 0.11% | 买入期权 |
| Quantinno Capital Management LP | $656743405 | 547546 | 0.11% | 股份 |
| Goelzer Investment Management, Inc. | $644679302 | 537488 | 0.10% | 股份 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $631148000 | 526202 | 0.10% | 股份 |
| PARNASSUS INVESTMENTS, LLC | $630257285 | 525464 | 0.10% | 股份 |
| BANK OF MONTREAL /CAN/ | $623256213 | 519627 | 0.10% | 股份 |
| Employees Provident Fund Board | $621615392 | 518259 | 0.10% | 股份 |
| CITIGROUP INC | $614947761 | 512700 | 0.10% | 卖出期权 |
| Assenagon Asset Management S.A. | $600944416 | 501025 | 0.10% | 股份 |
| Aberdeen Group plc | $582286083 | 485469 | 0.09% | 股份 |
| Clearbridge Investments, LLC | $579491277 | 483139 | 0.09% | 股份 |
| PFA Pension, Forsikringsaktieselskab | $579482599 | 483132 | 0.09% | 股份 |
| AMF Tjanstepension AB | $573419896 | 478077 | 0.09% | 股份 |
| DEUTSCHE BANK AG\ | $572292432 | 477137 | 0.09% | 股份 |
| STOREBRAND ASSET MANAGEMENT AS | $565821507 | 471742 | 0.09% | 股份 |
公司内部人士 83 位内幕人士 · 48 位高管 · 30 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| David A Ricks | President, Chair, and CEO | 2025年8月12日 P | 546601 | 0 | 0 | $0 |
| Lucas Montarce | EVP & CFO | 2025年8月15日 P | 14685 | 0 | 0 | $0 |
| Anat Ashkenazi | EVP & CFO | 2024年2月12日 A | 42330 | 0 | 0 | $0 |
| Derica W Rice | EVP-Global Services and CFO | 2017年2月1日 M | 38292 | 0 | 0 | $0 |
| Charles E Golden | Exec. Vice President and CFO | 2006年4月28日 F | 85249 | 0 | 0 | $0 |
| Maria A Crowe | President, Mfg. Operations | 2017年2月1日 M | 113581 | 0 | 0 | $0 |
| Frank M Deane | President, Mfg. Operations | 2012年2月1日 M | 33995 | 0 | 0 | $0 |
| Deirdre P Connelly | President, U.S. Operations | 2009年1月27日 A | 53681 | 0 | 0 | $0 |
| Lorenzo Tallarigo | President, Internat'l Opers. | 2008年3月31日 F | 64458 | 0 | 0 | $0 |
| Scott A Canute | President, Mfg. Operations | 2007年2月1日 F | 25367 | 0 | 0 | $0 |
| Patrik Jonsson | EVP & President, LLY Int'l | 2026年8月17日 S | 54147 | 0 | 1 | $-7638150 |
| Melissa Seymour | EVP, Global Quality | 2026年8月1日 M | 1067 | 0 | 0 | $0 |
| Ilya Yuffa | EVP&Pres, LLY USA&Global Capab | 2026年6月10日 S | 29804 | 0 | 1 | $-2876925 |
| Edgardo Hernandez | EVP & Pres., Mfg. Operations | 2025年9月5日 G | 39731 | 0 | 0 | $0 |
| Kenneth L. Custer | EVP & President, Card Met Hlth | 2025年8月27日 I | — | 0 | 0 | $0 |
| Jacob Van Naarden | EVP & Pres., Lilly Oncology | 2025年8月13日 P | 20562 | 0 | 0 | $0 |
| Daniel Skovronsky | EVP, CSO & Pres. LRL & LLY Imm | 2025年8月12日 P | 137660 | 0 | 0 | $0 |
| Eric Dozier | EVP, Chief People Officer | 2025年3月1日 M | 9839 | 0 | 0 | $0 |
| Diogo Rau | EVP & CIDO | 2025年2月10日 A | 19719 | 0 | 0 | $0 |
| Anne E. White | EVP & Pres, Lilly Neuroscience | 2025年2月10日 A | 74210 | 0 | 0 | $0 |
| Johna Norton | EVP, Global Quality | 2024年6月3日 S | 25428 | 0 | 0 | $0 |
| Alonzo Weems | EVP, ERM & CECO | 2024年2月12日 A | 7951 | 0 | 0 | $0 |
| Michael B Mason | EVP & Pres., Lilly Diabetes | 2023年2月10日 A | 39284 | 0 | 0 | $0 |
| Leigh Ann Pusey | EVP, Corp. Affairs & Comm. | 2023年2月10日 A | 31641 | 0 | 0 | $0 |
| Stephen F Fry | SVP, HR & Diversity | 2022年2月9日 A | 152631 | 0 | 0 | $0 |
| Myles O'Neill | SVP & Pres., Mfg. Operations | 2021年2月8日 A | 72533 | 0 | 0 | $0 |
| Alfonso G Zulueta | SVP & President, Lilly Int'l | 2021年2月8日 A | 56947 | 0 | 0 | $0 |
| Melissa S Barnes | Chief Eth/Cmpl Ofcr & SVP, ERM | 2021年2月8日 A | 34616 | 0 | 0 | $0 |
| Michael J Harrington | Senior VP and General Counsel | 2020年1月2日 A | 59500 | 0 | 0 | $0 |
| Christi Shaw | SVP and Pres., Lilly Bio-Meds | 2019年5月3日 S | 500 | 0 | 0 | $0 |
| Enrique A Conterno | SVP&Pres, LillyDiab & LillyUSA | 2019年2月4日 A | 157962 | 0 | 0 | $0 |
| Jeffrey N Simmons | SVP&Pres. Elanco Animal Health | 2018年5月1日 M | 135458 | 0 | 0 | $0 |
| Susan Mahony | SVP & Pres., Lilly Oncology | 2018年4月16日 S | 40685 | 0 | 0 | $0 |
| Jan M Lundberg | EVP,Science&Tech and Pres. LRL | 2018年2月9日 A | 198126 | 0 | 0 | $0 |
| Fionnuala M Walsh | SVP, Global Quality | 2017年2月1日 M | 67144 | 0 | 0 | $0 |
| Barton R Peterson | Sr. VP, Corp. Affairs & Comm. | 2017年2月1日 M | 108312 | 0 | 0 | $0 |
| Jacques Tapiero | SVP&Pres., Emerging Markets | 2014年1月28日 A | 55384 | 0 | 0 | $0 |
| Arnold C Hanish | Chief Accounting Officer | 2012年8月29日 G | 17611 | 0 | 0 | $0 |
| Bryce D. Carmine | EVP and Pres, Lilly Bio-Meds | 2012年2月1日 M | 102647 | 0 | 0 | $0 |
| Robert A Armitage | Sr. VP and General Counsel | 2012年2月1日 M | 97063 | 0 | 0 | $0 |
| Anne Nobles | Chief Eth/Cmpl Ofcr & SVP, ERM | 2012年1月26日 A | 23536 | 0 | 0 | $0 |
| Steven M Paul | EVP, Science and Technology | 2010年2月1日 M | 38897 | 0 | 0 | $0 |
| Anthony John Murphy | Senior VP, Human Resources | 2009年2月2日 F | 15231 | 0 | 0 | $0 |
| Gino Santini | Sr.VP, Corp. Strategy & BD | 2009年2月2日 F | 102174 | 0 | 0 | $0 |
| Alex M Azar II | Sr. VP, Corp. Affairs & Comm. | 2009年1月27日 A | 5000 | 0 | 0 | $0 |
| Sidney Taurel | Chairman | 2008年12月31日 F | 341806 | 0 | 0 | $0 |
| Gerhard N Mayr | EVP, Pharmaceutical Operations | 2004年2月17日 A | — | 0 | 0 | $0 |
| Pedro P Granadillo | Senior Vice President | 2004年2月17日 A | — | 0 | 0 | $0 |
| Juan R Luciano | 董事 | 2026年8月17日 A | 16918 | 0 | 0 | $0 |
| Erik J Fyrwald | 董事 | 2026年8月17日 A | 75418 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士;净额=仅公开市场买卖
激进投资者及 5%+ 股东 1 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权,意图影响发行人(激进股东持股、董事会活动、并购)。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| ELI LILLY AND COMPANY, SHENANDOAH ACQUISITION CORPORATION ×15 申报 | 2023年8月14日 | — | 初始申报 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF持仓 由 326 只交易所交易基金持有
权重仅反映直接股权持仓(N-PORT);杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| MEDI · Harbor ETF Trust | 20.10% | 5929 NS | 2026年4月30日 | N-PORT |
| ELIL · Direxion Shares ETF Trust | 15.27% | 3512 NS | 2026年4月30日 | N-PORT |
| GDOC · Goldman Sachs ETF Trust | 13.28% | 2417 NS | 2026年5月31日 | N-PORT |
| RXL · ProShares Trust | 12.67% | 8263 NS | 2026年5月31日 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 12.13% | 370443 NS | 2026年4月30日 | N-PORT |
| HRTS · Tema ETF Trust | 11.52% | 5413 NS | 2026年5月31日 | N-PORT |
| CURE · Direxion Shares ETF Trust | 10.68% | 15801 NS | 2026年4月30日 | N-PORT |
| SNPG · DBX ETF Trust | 7.01% | 852 NS | 2026年5月29日 | N-PORT |
| JDOC · J.P. Morgan Exchange-Traded Fund ... | 6.81% | 811 NS | 2026年4月30日 | N-PORT |
| LRND · New York Life Investments ETF Trust | 5.19% | 15945 NS | 2026年4月30日 | N-PORT |
| JGRW · Trust for Professional Managers | 4.90% | 4253 NS | 2026年5月31日 | N-PORT |
| CANC · Tema ETF Trust | 4.82% | 7684 NS | 2026年5月31日 | N-PORT |
| SXQG · EXCHANGE TRADED CONCEPTS TRUST | 4.78% | 2923 NS | 2026年5月31日 | N-PORT |
| BRIF · FIS Trust | 4.68% | 6248 NS | 2026年5月31日 | N-PORT |
| EGGS · Tidal Trust III | 4.43% | 2254 NS | 2026年5月31日 | N-PORT |
| FLAG · Global X Funds | 4.25% | 75 NS | 2026年4月30日 | N-PORT |
| CARK · Advisors' Inner Circle Fund II | 4.24% | 14041 NS | 2026年4月30日 | N-PORT |
| DUHP · Dimensional ETF Trust | 4.21% | 511432 NS | 2026年4月30日 | N-PORT |
| PJFG · PGIM ETF Trust | 4.16% | 5851 NS | 2026年5月29日 | N-PORT |
| AMOM · Exchange Listed Funds Trust | 4.05% | 1321 NS | 2026年4月30日 | N-PORT |
| MBCC · Northern Lights Fund Trust IV | 4.01% | 6688 NS | 2026年5月31日 | N-PORT |
| CGUS · Capital Group Core Equity ETF | 3.92% | 384824 NS | 2026年5月31日 | N-PORT |
| SEMG · EA Series Trust | 3.87% | 2506 NS | 2026年4月30日 | N-PORT |
| GFGF · EA Series Trust | 3.86% | 1296 NS | 2026年5月29日 | N-PORT |
| BWTG · ETF Opportunities Trust | 3.84% | 716 NS | 2026年5月31日 | N-PORT |
| BKCG · BNY Mellon ETF Trust II | 3.79% | 4808 NS | 2026年4月30日 | N-PORT |
| HFGO · Hartford Funds Exchange-Traded Trust | 3.66% | 7105 NS | 2026年4月30日 | N-PORT |
| RILA · Spinnaker ETF Series | 3.61% | 1620 NS | 2026年4月30日 | N-PORT |
| AGNG · Global X Funds | 3.58% | 2652 NS | 2026年5月31日 | N-PORT |
| AVIE · AMERICAN CENTURY ETF TRUST | 3.56% | 331 NS | 2026年5月31日 | N-PORT |
| EGGY · Tidal Trust III | 3.54% | 4039 NS | 2026年5月31日 | N-PORT |
| CGCV · Capital Group Conservative Equity... | 3.52% | 55867 NS | 2026年5月31日 | N-PORT |
| GDIV · Harbor ETF Trust | 3.51% | 8487 NS | 2026年4月30日 | N-PORT |
| ILDR · First Trust Exchange-Traded Fund ... | 3.45% | 8953 NS | 2026年5月31日 | N-PORT |
| GGUS · Goldman Sachs ETF Trust | 3.43% | 14301 NS | 2026年5月31日 | N-PORT |
| GROZ · Zacks Trust | 3.41% | 2787 NS | 2026年5月31日 | N-PORT |
| NEWZ · EA Series Trust | 3.33% | 675 NS | 2026年4月30日 | N-PORT |
| NUGO · Nushares ETF Trust | 3.26% | 99054 NS | 2026年4月30日 | N-PORT |
| EGGQ · Tidal Trust III | 3.20% | 2523 NS | 2026年5月31日 | N-PORT |
| CGDV · Capital Group Dividend Value ETF | 3.15% | 1003005 NS | 2026年5月31日 | N-PORT |
| SCHG · SCHWAB STRATEGIC TRUST | 3.05% | 1688536 NS | 2026年5月31日 | N-PORT |
| JXX · Janus Detroit Street Trust | 2.99% | 1160 NS | 2026年4月30日 | N-PORT |
| QUSA · Tidal Trust III | 2.99% | 567 NS | 2026年4月30日 | N-PORT |
| ESG · FlexShares Trust | 2.96% | 4061 NS | 2026年4月30日 | N-PORT |
| WLTG · ETF Opportunities Trust | 2.90% | 2354 NS | 2026年4月30日 | N-PORT |
| WINN · Harbor ETF Trust | 2.83% | 33020 NS | 2026年4月30日 | N-PORT |
| NBGX · Neuberger Berman ETF Trust | 2.82% | 382 NS | 2026年5月31日 | N-PORT |
| PJBF · PGIM ETF Trust | 2.79% | 296 NS | 2026年5月29日 | N-PORT |
| NULG · Nushares ETF Trust | 2.77% | 77375 NS | 2026年4月30日 | N-PORT |
| ACGR · AMERICAN CENTURY ETF TRUST | 2.73% | 282 NS | 2026年5月31日 | N-PORT |